EZH2 and hepatocellular carcinoma: By inhibiting the recruitment of EZH2 on the CXCL10 promoter, knockdown of HDAC-10 can promote the increase of CXCL10 expression in HCC, inducing the recruitment of T cells and NK cells, and regulating and controlling the anti-tumor response in the TME (144).